Inhibikase Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Inhibikase Therapeutics, Inc.

Welcome to our dedicated page for Inhibikase Therapeutics, Inc. (Nasdaq: IKT) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Inhibikase Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Inhibikase Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for IKT
TickerTime & DateFilingLink
IKT11:53:27 PM, 10/23/2024
Bellini Roberto purchased 1460000 shares of Inhibikase Therapeutics, Inc. (IKT) for ~$2000200
Filing
IKT11:49:49 PM, 10/23/2024
Kush Arvind purchased 145000 shares of Inhibikase Therapeutics, Inc. (IKT) for ~$198650
Filing
IKT11:43:35 PM, 10/23/2024
Munshi Amit purchased 365000 shares of Inhibikase Therapeutics, Inc. (IKT) for ~$500050
Filing